38.81

2.51% 0.95

Verona Pharma Plc Adr (VRNA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$37.86

Aprire:

$38.11

Volume 24 ore:

1.23M

Relative Volume:

1.23

Capitalizzazione di mercato:

$3.18B

Reddito:

Utile/perdita netta:

$-153.72M

Rapporto P/E:

-69.30

EPS:

-0.56

Flusso di cassa netto:

$-103.81M

1 W Prestazione:

+8.83%

1M Prestazione:

+11.30%

6M Prestazione:

+208.02%

1 anno Prestazione:

+176.23%

Intervallo 1D:

$37.67

$39.25

Intervallo di 1 settimana:

$34.51

$39.58

Portata 52W:

$11.39

$40.13

Verona Pharma Plc Adr Stock (VRNA) Company Profile

Nome

Verona Pharma Plc Adr

Settore

Healthcare (1195)

Industria

Biotechnology (683)

Telefono

011-44-0-2032834200

Indirizzo

3 MORE LONDON RIVERSIDE, LONDON

Dipendente

Cinguettio

@VeronaPharma

Prossima data di guadagno

2024-11-04

Ultimi documenti SEC

VRNA's Discussions on Twitter

Confronta VRNA con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
VRNA	38.81	3.18B	0	-153.72M	-103.81M	-0.56
VRTX	450.97	116.14B	10.63B	-479.80M	-1.35B	13.33
REGN	738.00	81.10B	13.85B	4.65B	3.32B	35.06
ARGX	605.92	36.23B	1.86B	-40.29M	-1.28B	-4.16
ALNY	244.89	31.59B	2.09B	-332.26M	16.06M	-4.14
BNTX	113.13	27.12B	3.30B	-501.07M	1.03B	11.54

Verona Pharma Plc Adr Stock (VRNA) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-05-22	Ripresa	Jefferies	Buy
2022-09-19	Ripresa	Wedbush	Outperform
2022-08-26	Iniziato	Piper Sandler	Overweight
2021-09-13	Iniziato	H.C. Wainwright	Buy
2020-08-25	Iniziato	Jefferies	Buy
2020-08-10	Iniziato	Canaccord Genuity	Buy
2019-04-18	Iniziato	BTIG Research	Buy

Mostra tutto

Verona Pharma Plc Adr Borsa (VRNA) Ultime notizie

Nov 07, 2024

Verona Pharma director Christina Ackermann acquires $198,385 in shares - Investing.com

Nov 07, 2024

Verona Pharma director David Ebsworth buys $188,880 in shares - Investing.com

Nov 07, 2024

Nov 05, 2024

Verona Pharma CFO Mark Hahn sells shares worth $568,386 - Investing.com

Nov 05, 2024

Nov 04, 2024

Earnings call: Verona Pharma reports Q3 results, optimistic on Ohtuvayre By Investing.com - Investing.com Nigeria

Nov 04, 2024

Earnings call: Verona Pharma reports Q3 results, optimistic on Ohtuvayre - Investing.com India

Nov 04, 2024

Exxon Mobil, Constellation Lead Afternoon Market Cap Stock Movers on Monday - Investing.com Nigeria

Nov 04, 2024

Exxon Mobil, Constellation Lead Afternoon Market Cap Stock Movers on Monday By Investing.com - Investing.com South Africa

Nov 04, 2024

Verona Pharma ADR earnings matched, revenue topped estimates By Investing.com - Investing.com UK

Nov 04, 2024

Verona Pharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire Inc.

Nov 04, 2024

Oct 25, 2024

Verona Pharma CFO Mark Hahn sells shares worth $632,760 - Investing.com India

Oct 25, 2024

Verona Pharma CEO David Zaccardelli sells shares worth $633,895 - Investing.com India

Oct 25, 2024

Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma - Barchart

Oct 25, 2024

Oct 24, 2024

5 Biotech Stocks Likely To Outperform As Industry Prospects Look Bright - Barchart

Oct 24, 2024

Oct 22, 2024

Verona Pharma CEO David Zaccardelli sells $2.25 million in shares - Investing.com India

Oct 22, 2024

Verona Pharma CEO David Zaccardelli sells $2.25 million in shares By Investing.com - Investing.com South Africa

Oct 22, 2024

Verona Pharma CFO Mark Hahn sells shares worth $2.3 million By Investing.com - Investing.com South Africa

Oct 22, 2024

Verona Pharma CFO Mark Hahn sells shares worth $2.3 million - Investing.com India

Oct 22, 2024

Oct 16, 2024

Market Insights: Verona Pharma Plc ADR (VRNA)’s Notable Drop of -0.55, Closing at 34.07 - The Dwinnex

Oct 16, 2024

Oct 15, 2024